Orphan drug status granted for Cytonet’s biotech liver treatment
Links shared publicly online about this topic.
- 437total visits
Orphan drug status granted for Cytonet’s biotech liver treatment
View full resource at medcitynews.com
Tags: Liver, Disease and Condition, Drug, Biotech
Most Recently Shared on March 15, 2011 at 6:13 pm By:
Orphan drug status granted for Cytonet’s biotech liver treatment http://bit.ly/g6xSeZ
FDA grants orphan status to Lexicon tumor drug, shares rise | Reuters
reuters.com — “(Reuters) - The U.S. Food and Drug Administration granted orphan drug status to Lexicon Pharmaceuticals Inc's experimental tumor drug, sending the biopharmaceutical company's shares up 11 percent in extended” View full resource at reuters.com
Most Recently Shared on March 20, 2012 at 11:07 pm By:
FDA grants orphan status to Lexicon tumor drug, shares rise http://t.co/9ZyBIue6
Central serous chorioretinopathy treatment granted orphan drug status
osnsupersite.com — “VANCOUVER, British Columbia — The U.S. Food and Drug Administration has granted orphan drug designation to QLT for Visudyne as a potential treatm” View full resource at osnsupersite.com
Most Recently Shared on March 20, 2012 at 2:55 pm By:
Central serous chorioretinopathy treatment granted orphan drug status: http://t.co/CYIoHC5r - #QLT #Visudyne
QLT's eye drug gets orphan designation in U.S. - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - Canadian biotechnology company QLT Inc said the U.S. health regulator granted an orphan status to its key eye drug. The drug, Visudyne, is already approved as a treatment for age-related macular degeneration, a cause of blindness in people over the age of 55, and the company is now seeking approval for chronic or recurrent central serous chorioretinopathy (CSC). CSC symptoms include blind spots in the central visual field, reduced contrast sensitivity and color visi” View full resource at news.yahoo.com
Most Recently Shared on March 19, 2012 at 12:38 pm By:
HealthTrendster Health Executive
QLT's eye drug gets orphan designation in U.S. - (Reuters) - Canadian biotechnology company QLT Inc said the U.S. he... http://t.co/75NOZZBm
QLT's eye drug gets orphan designation in U.S.
health.yahoo.net — “(Reuters) - Canadian biotechnology company QLT Inc said the U.S. health regulator granted an orphan status to its key eye drug.” View full resource at health.yahoo.net
Most Recently Shared on March 19, 2012 at 12:12 pm By:
Jane Anderson Healthy Eating Advisor
QLT's eye drug gets orphan designation in U.S. http://t.co/7AUq1CDN
QLT's eye drug gets orphan designation in U.S. | Reuters
reuters.com — “(Reuters) - Canadian biotechnology company QLT Inc said the U.S. health regulator granted an orphan status to its key eye drug.The drug, Visudyne, is already approved as a treatment for age-related macular” View full resource at reuters.com
Most Recently Shared on March 19, 2012 at 12:02 pm By:
QLT's eye drug gets orphan designation in U.S.: (Reuters) - Canadian biotechnology company QLT Inc... http://t.co/AocFLPvX #health #news
QLT's eye drug gets orphan designation in U.S.
health.yahoo.net — “(Reuters) - Canadian biotechnology company QLT Inc said the U.S. health regulator granted an orphan status to its key eye drug.” View full resource at health.yahoo.net
Most Recently Shared on March 19, 2012 at 12:01 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
QLT's eye drug gets orphan designation in U.S.: (Reuters) - Canadian biotechnology company QLT Inc said the U.S.... http://t.co/Hbymh3mf
QLT's eye drug gets orphan designation in U.S. | Reuters
reuters.com — “(Reuters) - Canadian biotechnology company QLT Inc said the U.S. health regulator granted an orphan status to its key eye drug.The drug, Visudyne, is already approved as a treatment for age-related macular” View full resource at reuters.com
Most Recently Shared on March 19, 2012 at 11:41 am By:
QLT's eye drug gets orphan designation in U.S. http://t.co/klhKmfwG
QLT's eye drug gets orphan designation in U.S. | Reuters
reuters.com — “(Reuters) - Canadian biotechnology company QLT Inc said the U.S. health regulator granted an orphan status to its key eye drug.The drug, Visudyne, is already approved as a treatment for age-related macular” View full resource at reuters.com
Most Recently Shared on March 19, 2012 at 11:36 am By:
QLT's eye drug gets orphan designation in U.S.: (Reuters) - Canadian biotechnology company QLT Inc said the U.S.... http://t.co/LPVaKT2j
QLT's eye drug gets orphan designation in U.S. | Reuters
reuters.com — “(Reuters) - Canadian biotechnology company QLT Inc said the U.S. health regulator granted an orphan status to its key eye drug.The drug, Visudyne, is already approved as a treatment for age-related macular” View full resource at reuters.com
Most Recently Shared on March 19, 2012 at 11:36 am By:
QLT's eye drug gets orphan designation in U.S. http://t.co/iKxuywzO
Corneal cross-linking treatment for ectasia granted orphan drug status
osnsupersite.com — “WALTHAM, Mass. — A corneal cross-linking treatment for corneal ectasia after refractive surgery has been designated an orphan drug by the U.S. Fo” View full resource at osnsupersite.com
Most Recently Shared on December 7, 2011 at 5:15 pm By:
2nd designation: http://t.co/w55B0FMI -- Corneal cross-linking treatment for ectasia granted @US_FDA orphan drug status
Orphan Drug Status for Sirolimus for Non-Infectious Uveitis - MPR
empr.com — “Santen Inc. announced that the FDA has granted orphan drug designation for sirolimus (DE-109) for the treatment of chronic/refractory anterior non-infectious uveitis, non-infectious intermediate uveitis, non-infectious panuveitis, and non-infectious uveitis affecting the posterior segment of the eye.” View full resource at empr.com
Most Recently Shared on November 11, 2011 at 2:32 pm By:
Orphan Drug Status for Sirolimus for Non-Infectious #Uveitis http://t.co/vLl947Hz
EU grants orphan drug status to BioAlliance Pharma’s clonidine Lauriad | Oral Cancer News
oralcancernews.org — “EU grants orphan drug status to BioAlliance Pharma’s clonidine Lauriad | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on November 6, 2011 at 12:14 pm By:
Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF
news-medical.net — “Digna Biotech, a Spanish biotechnological company, announces that the Food and Drug Administration (FDA) granted cardiotrophin-1 (CT-1) Orphan Drug status for use in the treatment of acute liver failure.” View full resource at news-medical.net
Most Recently Shared on September 22, 2011 at 6:41 am By:
Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF: Digna Biotech, a Spanish biotech... http://t.co/UihqztlN
European Commission grants orphan drug designation for sirolimus for chronic noninfectious uveitis
osnsupersite.com — “EMERYVILLE, Calif. — The European Commission has granted orphan drug status for the use of the sirolimus drug DE-109 in the treatment of chronic” View full resource at osnsupersite.com
Most Recently Shared on September 9, 2011 at 6:30 pm By:
European Commission grants orphan drug designation for #sirolimus for chronic noninfectious #uveitis http://ht.ly/6pYW5
EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis
news-medical.net — “Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.” View full resource at news-medical.net
Most Recently Shared on September 8, 2011 at 11:42 am By:
EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis: Santen Inc., ... http://t.co/Vn00WUc
Advertisement
